XNAS · AIDX
-1.14% · -$0.0066 · Vol 233.2K
Market closed · last close 4:00 PM ET · price as of 19:15:48 ET
20/20 Biolabs, Inc. Common Stock

20/20 Biolabs, Inc. Common Stock

SERVICES-TESTING LABORATORIES
$0.5715
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is AIDX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for AIDX are being assembled.
About 20/20 Biolabs, Inc. Common Stock
SERVICES-TESTING LABORATORIES
Listed since
2026
Employees
14
Country
US

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.5781
Day high
$0.6200
Day low
$0.5500
Previous close
$0.5781
52W high
$0.8792
-35.00% from high
52W low
$0.5500
7% of range
Market cap
$7.1M
EPS
$-1.1200
Shares out
12.3M
Volume
233.2K
VWAP
$0.5806
Price history computed in-house
1W
-7.40%
1M
-32.75%
SMA 50 $0.6341 · below
SMA 200 $0.6341 · below
52W position 7%
Veridion warehouse edge

Warehouse intelligence for AIDX.

Veridion Score
24
0: 451: 442: 163: Not reported4: Not reported5: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

AIDX insider activity

20/20 Biolabs, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for AIDX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

AIDX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AIDX in this window.
Lobbying spend

AIDX lobbying filings, year to date.

Registered lobbying filings matched to 20/20 Biolabs, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AIDX in this window.
Latest news · AIDX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for AIDX.
Options
Sovereign unlock shows live options positioning for AIDX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.